Curocell

Curocell PP&E per Employee

PP&E per Employee of Curocell (372320.KQ) as of Oct 20, 2026.

PP&E per Employee

-KRW

Last updated:

PP&E per Employee of Curocell is 2026 - KRW. PP&E per Employee of Curocell was 2025 - KRW. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Curocell Stock analysis

What does Curocell do? Curocell Inc is a South Korean company headquartered in Daejeon operating in the biotechnology sector. The company focuses on the research and development of drugs, particularly developing CAR-T therapy technologies for cancer treatment. These include targeting novel cancer antigens, improving medicinal effects, reducing side effects, and automating quality analysis. Curocell Inc completed its IPO on November 9, 2023. The company's website is https://www.curocellbtx.com. Curocell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curocell stock

On Eulerpool you can find the complete historical development of PP&E per Employee Curocell since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Curocell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Curocell

All Key Metrics — Curocell